1. Home
  2. CNEY vs ALBT Comparison

CNEY vs ALBT Comparison

Compare CNEY & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CN Energy Group Inc.

CNEY

CN Energy Group Inc.

HOLD

Current Price

$1.02

Market Cap

5.7M

Sector

Industrials

ML Signal

HOLD

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$0.89

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNEY
ALBT
Founded
2009
2014
Country
China
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNEY
ALBT
Price
$1.02
$0.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4M
151.1K
Earning Date
02-13-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,573,432.00
$1,611,940.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.51
52 Week High
$10.25
$11.66

Technical Indicators

Market Signals
Indicator
CNEY
ALBT
Relative Strength Index (RSI) 59.98 50.80
Support Level $0.95 $0.51
Resistance Level $1.10 $0.91
Average True Range (ATR) 0.12 0.08
MACD 0.01 0.04
Stochastic Oscillator 82.57 96.63

Price Performance

Historical Comparison
CNEY
ALBT

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: